Skip to main content
. 2021 Jan 7;270:113687. doi: 10.1016/j.socscimed.2021.113687

Table 1.

Comparison of summary statistics between the North American baseline sample (N = 4166) and the analytic sample (N = 2463).

Variables
Full Baseline Sample
Final Analytic Sample
p (t/χ2)
Mean (SD) or %
Mean (SD) or %
Depressive symptoms
 Baseline Depressed (CESD-10 ≥ 10) 72.7% 70.6% .075
 Follow-up Depressed (CESD-10 ≥ 10) 69.8%
 Baseline CESD-10 13.50 (5.51) 13.12 (5.44) .007
 Follow-up CESD-10 12.91 (5.29)
Age 42.66 (15.42) 44.94 (15.32) <.001
Health 4.59 (0.97) 4.65 (0.95) .017
Income 2.43 (1.24) 2.47 (1.23) .203
Gender .405
 Men 14.5% 14.6%
 Women 75.9% 83.6%
 Other 1.8% 1.7%
Ethnicity .004
 White 84.0% 88.4%
 Other 16.0% 11.6%
Household Size 2.56 (1.39) 2.48 (1.37) .011
Countries .526
 Canada 71.7% 72.4%
 USA 28.3% 27.6%
Primary stressors
 Self-threat 3.20 (0.91) 3.22 (0.89) .441
 Other-threat 2.86 (1.09) 2.83 (1.07) .233
Secondary stressors
 Financial Insecurity 2.45 (1.09) 2.39 (1.09) .030
 Occupational difficulty 54.3% 52.2% .098
 Social Isolation 55.4% 53.4% .124
 Resource Scarcity 53.1% 53.8% .651
Time at baseline 24.11 (17.69) 23.48 (15.93) .134

Note. t-test was used with continuous variables and χ2 test with categorical variables. Time of baseline assessment was assessed as days elapsed between participants completing the baseline survey entry and the World Health Organization pandemic announcement (March 11, 2020; World Health Organization, 2020).